Validation Study in Healthy Female Volunteers: A Comparison of Two Neurotech Vital Devices Set up to Provide Different Types of Electrical Stimulation
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Dahlonega |
| State: |
|
Georgia |
| Zip Code: |
|
30597 |
| Conditions: |
|
Healthy Female Volunteers |
| Purpose: |
|
This research is being carried out in order to compare two alternative versions of the
Neurotech Vital Devices which have been set up to provide two different types of
stimulation. Both these devices will be fully functioning devices and the investigators want
to collect information on your perception of the two alternative modes. The patient will be
asked to provide feedback on both devices which will look identical. The patient will not be
told in which order the units were given to them until the completion of your visit.
|
| Study Summary: |
|
The Neurotech Vital Device is connected to a series of conductive hydrogel electrodes
strategically positioned in and around the pelvic area of the user. The electrode positions
and current pathways deliver therapeutic stimulation to the pelvic floor muscles resulting
in repeated contraction of the intended muscle group. Pilot study data has shown this novel
approach to produce extremely favorable adaptation and improvement in patient's symptoms
following intervention. In order to capture the intended electrode position a stand-alone
garment that will allow the end user to re-position electrodes on multiple re-applications
is required. The Neurotech Vital Device garment is CE Marked as a Class IIa medical device
and it is CE Marked, as part of the Neurotech Vital Device, in line with Medical Device
Directive 93/42/EC as amended by 2007/47/EC. The Neurotech Vital Device garment is not
cleared by the FDA through the 510 (k) pre-market notification process in the USA but would
be considered a Class II device as part of the Neurotech Vital Device.
The purpose of this validation study is to establish the suitability of the Neurotech Vital
device in which the treatment stimulation parameters have been markedly attenuated (defined
as 'modified Neurotech Vital device') prior to its use as one of the treatments in a
randomised, controlled, double-blind study to be conducted in patients with stress urinary
incontinence in Germany (Study No: BMR-11-1002).
|
| Criteria: |
|
Inclusion Criteria:
- Subjects who are female and at least 18 years of age.
- Subjects who, in the opinion of the Investigator, are deemed healthy.
- Subjects who are able to give voluntary, written informed consent to participate in
this study and from whom consent has been obtained.
- Subjects who are able to understand this study and are willing to complete all the
study assessments.
Exclusion Criteria:
- Subjects who have a physical condition that would make them unable to perform the
study procedures.
- Subjects with a history of any chronic respiratory condition (ie emphysema, chronic
obstructive pulmonary disease).
- Subjects with a history of an underlying neurological condition.
- Subjects with a history of low back pain involving the spinal nerve root.
- Subjects with a blood clotting disorder or who are taking anti-coagulant medications.
- Subjects who have previously had any uro-gynaecological related surgery excluding
hysterectomy.
- Subjects with a clinical diagnosis of prolapse greater than Stage 2.
- Subjects who are pregnant or could be pregnant.
- Subjects who are less than 6 months post-partum or who are lactating.
- Subjects who have any intra-uterine devices or metal implants in the pelvic area,
including hip and lumbar spine.
- Subjects with pelvic pain or fibromyalgia or paravaginal defect.
- Subjects with an active implanted medical device (ie pacemaker, pump etc).
- Subjects with a history of heart disease or stroke.
- Subjects with a known cancer.
- Subjects with an injury or disability affecting any part of their body which will be
in contact with the garment.
- Subjects who are currently involved in any injury litigation claims.
- Subjects who have been committed to an institution by virtue of an order issued
either by the courts or by an authority.
- Subjects who have participated in a clinical study in the last 3 months.
|
| NCT ID: |
|
NCT01632748 |
| Primary Contact: |
|
N/A |
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Dahlonega, Georgia 30597 United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 20, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|